336
Participants
Start Date
May 2, 2016
Primary Completion Date
January 5, 2021
Study Completion Date
January 5, 2021
Luspatercept
Subjects will start with luspatercept at 1 mg/kg dose level.
Placebo
Placebo, Subcutaneous, every 21 days.
Changhua Christian Hospital, Changhua
Kaohsiung Medical University Hospital, Kaohsiung City
Bone Marrow Transplant Center, Tunis
Aziza Othmana Hospital, Tunis
Military Hospital of Tunis, Tunis
Specialized Hospital for Active Treatment of Haematological Diseases - Sofia, Sofia
Prince of Wales Hospital, Randwick
Royal Prince Alfred Hospital, Camperdown
Monash Medical Centre, Clayton
University Mulitiprofile Hospital for Active Treatment Sveti Georgi EAD, Plovdiv
University Hospital Farhat Hached, Sousse
Mater Hospital Brisbane, South Brisbane
Royal Adelaide Hospital Institute of Medical and Veterinary Science, Adelaide
Sir Charles Gairdner Hospital, Nedlands
Multiprofile Hospital for Active Treatment Sveta Marina EAD, Varna
National Taiwan University Hospital, Taipei, Zhongzheng Dist.
Azienda Ospedaliero Universitaria S. Luigi Gonzaga, Orbassano
Weill Cornell Medical College, New York
Chulalongkorn University Faculty of Medicine - King Chulalongkorn Memorial Hospital, Bangkok
Siriraj Hospital Mahidol University, Bangkok
Hospital Pulau Pinang c/o Penang Medical College, George Town
General Hospital Georgios Gennimatas of Athens, Athens
Hopitaux de La Timone, Marseille
Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite, Genoa
HaEmek Medical Center, Haïfa (Afula)
Hospital of the University of Pennsylvania, Philadelphia
Fondazione Ca Granda IRCCS Ospedale Maggiore, Milan
Galilee Medical Center, Nahariya
University General Hospital of Patras, Rio Patras
Hospital Raja Permaisuri Bainun, Ipoh
Mersin University Medical Faculty, Mersin
Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi, Istanbul
Ege Universitesi Tip Fakultesi Hastanesi, Izmir
Azienda Ospedaliera Universitaria Integrata Di Verona, Verona
China Medical University Hospital, Taichung
Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale Sant'Anna, Ferrara
Rabin Medical Center, Petah Tikva
Chiang Mai University - Maharaj Nakorn Chiang Mai Hospital, Chiang Mai
Hippokration Hospital, Thessaloniki
Local Institution - 404, Thessaloniki
GH de Institut Catholique St. VincentHématologie, Lille
University Malaya Medical Centre, Kuala Lumpur
Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago
Presidio Ospedaliero Antonio Perrino, Brindisi
Hospital of Necker, Paris
Hospital Sultanah Aminah, Johor Bahru
Seconda Universita Degli Studi Di Napoli, Naples
AORN A Cardarelli, Napoli
Soroka University Medical Centre, Beersheba
Queen Elizabeth Hospital, Kota Kinabalu
Children's Hospital of Los Angeles, Los Angeles
Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo
Shaare Zedek Medical Center, Jerusalem
Hadassah Medical Center, Jerusalem
Hospital Umum Sarawak, Kuching
Hopital Henri Mondor, Créteil
Children's Hospital and Research Center at Oakland, Oakland
Rambam Health Corporation, Haifa
Boston Children's Hospital, Boston
University Health Network, Toronto
Laiko General Hospital of Athens, Ampelokipi - Athens
Local Institution - 405, Ampelokipi - Athens
"General Children's Hospital Agia Sophia", Athens
Universita degli Studi di Cagliari - ASL8, Cagliari
Chronic Care Center, Beirut
Hospital Sultanah Bahiyah, Alor Star
Acibadem Adana Hospital, Adana
Cukurova University Medical Faculty Balcali Hospital, Adana
Local Institution - 524, Adana
Hacettepe Universitesi, Ankara
Antalya Egitim Arastirma, Antalya
St James University Hospital, Leeds
Barts Health NHS Trust - The Royal London Hospital, London
Whittington Hospital, London
University College Hospital Trust, London Bloomsbury
Manchester Royal Infirmary, Manchester
Lead Sponsor
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
INDUSTRY
Celgene
INDUSTRY